{
    "PMC": "6275697",
    "DOI": "10.2478/s11658-006-0011-9",
    "PMID": "16847754",
    "PMCID": "PMC6275697",
    "title": "Degradation and beyond: control of androgen receptor activity by the proteasome system.",
    "year": 2006,
    "source_url": "https://europepmc.org/article/PMC/PMC6275697",
    "source": "MED",
    "abstract_text": "The androgen receptor (AR) is a transcription factor belonging to the family of nuclear receptors which mediates the action of androgens in the development of urogenital structures. AR expression is regulated post-translationally by the ubiquitin/proteasome system. This regulation involves more complex mechanisms than typical degradation. The ubiquitin/proteasome system may regulate AR via mechanisms that do not engage in receptor turnover. Given the critical role of AR in sexual development, this complex regulation is especially important. Deregulation of AR signalling may be a causal factor in prostate cancer development. AR is the main target in prostate cancer therapies. Due to the critical role of the ubiquitin/proteasome system in AR regulation, current research suggests that targeting AR degradation is a promising approach.",
    "full_text": "Cell Mol Biol Lett Cell. Mol. Biol. Lett Cellular & Molecular Biology Letters 1425-8153 1689-1392 Versita Warsaw 6275697 16847754 11 10.2478/s11658-006-0011-9 Article Degradation and beyond: Control of androgen receptor activity by the proteasome system Jaworski Tomasz tomasz_jaworski@poczta.onet.pl grid.413454.3 0000000119580162 Department of Cellular Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland 01 03 2006 3 2006 11 1 109 6 12 2005 31 1 2006 \u00a9 University of Wroc\u0142aw 2006 The androgen receptor (AR) is a transcription factor belonging to the family of nuclear receptors which mediates the action of androgens in the development of urogenital structures. AR expression is regulated post-translationally by the ubiquitin/proteasome system. This regulation involves more complex mechanisms than typical degradation. The ubiquitin/proteasome system may regulate AR via mechanisms that do not engage in receptor turnover. Given the critical role of AR in sexual development, this complex regulation is especially important. Deregulation of AR signalling may be a causal factor in prostate cancer development. AR is the main target in prostate cancer therapies. Due to the critical role of the ubiquitin/proteasome system in AR regulation, current research suggests that targeting AR degradation is a promising approach. Key words AR Degradation Prostate cancer Proteasome Transcription Ubiquitin issue-copyright-statement \u00a9 University of Wroc\u0142aw 2006 Abbreviations used AATF apoptosis antagonizing factor APIS complex AAA proteins independent of 20S ARA54 AR-associated protein 54 ARA70 AR-associated protein 70 ARE androgen responsive element ARNIP AR N-terminal interacting protein bFGF basic fibroblast growth factor CARM1 coactivator-associated arginine methyltransferase 1 CHIP C-terminus Hsp70 interacting protein DBD DNA binding domain E6-AP E6-associated protein GRIP-1 glucocorticoid receptor interacting protein 1 GSK3\u03b2 glycogen synthase kinase 3\u03b2 HDAC1 histone deacetylase 1 HECT homologous to the E6-AP C-terminus HEK293 human embryonal kidney cell line HepG2 human hepatoma cell line Hsp90 heat shock protein 90 IGF-1 insulin-like growth factor 1 IL-6 interleukin 6 KLK2 kallikrein 2 KLKK lysine (K), leucine (L) LBD ligand binding domain LNCaP lymph node carcinoma of prostate cell line MAPK mitogen activated protein kinase Mdm2 Murine double minute 2 NcoR nuclear receptor corepressor NEDD8 neural precursor cell-expressed developmentally down-regulated NLS nuclear localisation signal p/CAF p300/CBP-associated factor p300/CBP CREB-binding protein PC3 human prostate carcinoma cell line PEST proline (P), glutamic acid (E), serine (S), threonine (T) PI3K phosphoinositide-3 kinase PIAS1 protein inhibitor of activated STAT PKA protein kinase A PKC protein kinase C PR progesterone receptor PRMT1 protein arginine methyltransferase 1 PROTAC proteolysis targeting chimeric molecule PSA prostate specific antigen PSMA7 proteasome alpha subunit 7 P-TEFb positive transcription elongation factor b PTEN phosphatase and tensin homolog deleted on chromosome 10 RING really interesting new gene RNA Pol II RNA polymerase II SCF ligase Skp2/cullin1/F-box SMRT silencing mediator of retinoic acid and thyroid hormone receptor SNURF small nuclear RING finger SRC1 steroid receptor coactivator 1 Sugl suppressor of Gal SUMO small ubiquitin-like modifier SWI/SNF mating type switching/sucrose non-fermenting TBL1 transducin-\u03b2-like TBLR1 transduction-\u03b2-like-related protein TBP TATA binding protein TFIIB, D, F, H general transcription factors TRAP thyroid hormone receptor-associated protein TSG101 tumour susceptibility gene 101 UAC ubiquitin activating enzyme UBC ubiquitin conjugating enzyme References 1. Wilson J.D. George F.W. Griffin J.E. The hormonal control of sexual development Science 1981 211 1278 1284 7010602 2. Quigley C.A. De Bellis A. Marschke K.B. El-Awady M.K. Wilson E.M. French F.S. Androgen receptor defects: historical, clinical and molecular perspectives Endocr. Rev. 1995 16 271 321 10.1210/er.16.3.271 7671849 3. Grossmann M.E. Huang H. Tindall D.J. Androgen receptor signaling in androgen-refractory prostate cancer J. Natl. Cancer Inst. 2001 93 1687 1697 10.1093/jnci/93.22.1687 11717329 4. Jemal A. Murray T. Ward E. Samuels A. Tiwari R.C. Ghafoor A. Feuer E.J. Thun M.J. Cancer statistics, 2005 CA Cancer J. Clin. 2005 55 10 30 10.3322/canjclin.55.1.10 15661684 5. www.nursa.org 6. MacLean H.E. Warne G.L. Zajac J.D. Localization of functional domains in the androgen receptor J. Steroid Biochem. Mol. Biol. 1997 62 233 242 10.1016/S0960-0760(97)00049-6 9408077 7. Vanaja D.K. Mitchell S.H. Toft D.O. Young C.Y. Effect of geldanamycin on androgen receptor function and stability Cell Stress Chaperones 2002 7 55 64 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2 11894840 8. Shang Y. Myers M. Brown M. Formation of androgen receptor transcription complex Mol. Cell 2002 9 601 610 10.1016/S1097-2765(02)00471-9 11931767 9. Asirvatham A.J. Schmidt M. Gao B. Chaudhary J. Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells Endocrinology 2006 147 257 271 10.1210/en.2005-0942 16195407 10. Burnstein K.L. Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy J. Cell. Biochem. 2005 95 657 669 10.1002/jcb.20460 15861399 11. Yeap B.B. Wilce J.A. Leedman P.J. The androgen receptor mRNA BioEssays 2004 26 672 682 10.1002/bies.20051 15170865 12. Heinlein C.A. Chang C. Androgen receptor (AR) coregulators: an overview Endocr. Rev. 2002 23 175 200 10.1210/er.23.2.175 11943742 13. Smith C.L. O\u2019Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators Endocr. Rev. 2004 25 45 71 10.1210/er.2003-0023 14769827 14. Sheflin L. Keegan B. Zhang W. Spaulding S.W. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels Biochem. Biophys. Res. Commun. 2000 276 144 150 10.1006/bbrc.2000.3424 11006097 15. Pickart C.M. Mechanisms underlying ubiquitination Annu. Rev. Biochem. 2001 70 503 533 10.1146/annurev.biochem.70.1.503 11395416 16. Thrower J.S. Hoffman L. Rechsteiner M. Pickart C.M. Recognition of the polyubiquitin proteolytic signal EMBO J. 2000 19 94 102 10.1093/emboj/19.1.94 10619848 17. Nawaz Z. Lonard D.M. Smith C.L. Lev-Lehman E. Tsai S.Y. Tsai M.J. O\u2019Malley B.W. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily Mol. Cell. Biol. 1999 19 1182 1189 9891052 18. Smith C.L. DeVera D.G. Lamb D.J. Nawaz Z. Jiang Y.H. Beaudet A.L. O\u2019Malley B.W. Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction Mol. Cell. Biol. 2002 22 525 535 10.1128/MCB.22.2.525-535.2002 11756548 19. Verma S. Ismail A. Gao X. Fu G. Li X. O\u2019Malley B.W. Nawaz Z. The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors Mol. Cell. Biol. 2004 24 8716 8726 10.1128/MCB.24.19.8716-8726.2004 15367689 20. Beitel L.K. Elhaji Y.A. Lumbroso R. Wing S.S. Panet-Raymond V. Gottlieb B. Pinsky L. Trifiro M.A. Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity J. Mol. Endocrinol. 2002 29 41 60 10.1677/jme.0.0290041 12200228 21. Kang H.Y. Yeh S. Fujimoto N. Chang C. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor J. Biol. Chem. 1999 274 8570 8576 10.1074/jbc.274.13.8570 10085091 22. Ito K. Adachi S. Iwakami R. Yasuda H. Muto Y. Seki N. Okano Y. N-Terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8 Eur. J. Biochem. 2001 268 2725 2732 10.1046/j.1432-1327.2001.02169.x 11322894 23. Lin H.K. Wang L. Hu Y.C. Altuwaijri S. Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase EMBO J. 2002 21 4037 4048 10.1093/emboj/cdf406 12145204 24. Moilanen A.M. Karvonen U. Poukka H. Yan W. Toppari J. J\u00e4nne O.A. Palvimo J.J. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins J. Biol. Chem. 1999 274 3700 3704 10.1074/jbc.274.6.3700 9920921 25. Poukka H. Aarnisalo P. Karvonen U. Palvimo J.J. J\u00e4nne O.A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription J. Biol. Chem. 1999 274 19441 19446 10.1074/jbc.274.27.19441 10383460 26. Poukka H. Karvonen U. J\u00e4nne O.A. Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1) Proc. Natl. Acad. Sci. USA 2000 97 14145 14150 10.1073/pnas.97.26.14145 11121022 27. Nishida T. Yasuda H. PIAS1 and PIASx\u03b1 function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription J. Biol. Chem. 2002 277 41311 41317 10.1074/jbc.M206741200 12177000 28. Moilanen A.M. Poukka H. Karvonen U. H\u00e4kli M. J\u00e4nne O.A. Palvimo J.J. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription Mol. Cell. Biol. 1998 18 5128 3519 9710597 29. Poukka H. Karvonen U. Yoshikawa N. Tanaka H. Palvimo J.J. J\u00e4nne O.A. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor J. Cell. Sci. 2000 113 2991 3001 10934038 30. H\u00e4kli M. Lorick K.L. Weissman A.M. J\u00e4nne O.A. Palvimo J.J. Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity FEBS Letters 2004 560 56 62 10.1016/S0014-5793(04)00070-5 14987998 31. Murata S. Minami Y. Minami M. Chiba T. Tanaka K. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein EMBO Rep. 2001 2 1133 1138 10.1093/embo-reports/kve246 11743028 32. Cardozo C.P. Michaud C. Ost M.C. Fliss A.E. Yang E. Patterson C. Hall S.J. Caplan A.J. C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation Arch. Biochem. Biophys. 2003 410 134 140 10.1016/S0003-9861(02)00680-X 12559985 33. He B. Bai S. Hnat A.T. Kalman R.I. Minges J.T. Patterson C. Wilson E.M. An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP) J. Biol. Chem. 2004 279 30643 30653 10.1074/jbc.M403117200 15107424 34. Rechsteiner M. Rogers S.W. PEST sequences and regulation by proteolysis Trends Biochem. Sci. 1996 21 267 271 10.1016/0968-0004(96)10031-1 8755249 35. Wolf D.H. Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal Biochim. Biophys. Acta 2004 1695 19 31 10.1016/j.bbamcr.2004.10.007 15571806 36. Lin H.K. Hu Y.C. Lee D.K. Chang C. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells Mol. Endocrinol. 2004 18 2409 2423 10.1210/me.2004-0117 15205473 37. Yang L. Wang L. Lin H.K. Kan P.Y. Xie S. Tsai M.Y. Wang P.H. Chen Y.T. Chang C. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells Biochem. Biophys. Res. Commun. 2003 305 462 469 10.1016/S0006-291X(03)00792-7 12763015 38. Cronauer M.V. Nessler-Menardi C. Klocker H. Maly K. Hobisch A. Bartsch G. Culig Z. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells Br. J. Cancer 2000 82 39 45 10.1054/bjoc.1999.0874 10638964 39. Lin H.K. Yeh S. Kang H.Y. Chang C. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor Proc. Natl. Acad. Sci. USA 2001 98 7200 7205 10.1073/pnas.121173298 11404460 40. Hu Y.C. Yeh S. Yeh S.D. Sampson E.R. Huang J. Li P. Hsu C.L. Ting H.J. Lin H.K. Wang L. Kim E. Ni J. Chang C. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer J. Biol. Chem. 2004 279 33438 33446 10.1074/jbc.M401781200 15166229 41. Lin H.K. Hu Y.C. Yang L. Altuwaijri S. Chen Y.T. Kang H.Y. Chang C. Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers J. Biol. Chem. 2003 278 50902 50907 10.1074/jbc.M300676200 14555644 42. Wen Y. Hu M.C. Makino K. Spohn B. Bartholomeusz G. Yan D.H. Hung M.C. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway Cancer Res. 2000 60 6841 6845 11156376 43. Salas T.R. Kim J. Vakar-Lopez F. Sabichi A.L. Troncoso P. Jenster G. Kikuchi A. Chen S.Y. Shemshedini L. Suraokar M. Logothetis C.J. DiGiovanni J. Lippman S.M. Menter D.G. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity J. Biol. Chem. 2004 279 19191 19200 10.1074/jbc.M309560200 14985354 44. Liao X. Thrasher J.B. Holzbeierlein J. Stanley S. Li B. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer Endocrinology 2004 145 2941 2949 10.1210/en.2003-1519 14988390 45. Gioeli D. Black B.E. Gordon V. Spencer A. Kesler C.T. Eblen S.T. Paschal B.M. Weber M.J. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization Mol. Endocrinol. 2006 20 503 515 10.1210/me.2005-0351 16282370 46. Fu M. Wang C. Zhang X. Pestell R.G. Acetylation of nuclear receptors in cellular growth and apoptosis Biochem. Pharmacol. 2004 68 1199 1208 10.1016/j.bcp.2004.05.037 15313417 47. Ito A. Kawaguchi Y. Lai C.H. Kovacs J.J. Higashimoto Y. Appella E. Yao T.P. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation EMBO J. 2002 21 6236 6245 10.1093/emboj/cdf616 12426395 48. Cidlowski J.A. Cidlowski N.B. Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells Endocrinology 1981 109 1975 1982 10.1210/endo-109-6-1975 7308136 49. Dace A. Zhao L. Park K.S. Furuno T. Takamura N. Nakanishi M. West B.L. Hanover J.A. Cheng S. Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors Proc. Natl. Acad. Sci. USA 2000 97 8985 8990 10.1073/pnas.160257997 10908671 50. Zhu J. Gianni M. Kopf E. Honore N. Chelbi-Alix M. Koken M. Quignon F. Rochette-Egly C. de The H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins Proc. Natl. Acad. Sci. USA 1999 96 14807 14812 10.1073/pnas.96.26.14807 10611294 51. Lange C.A. Shen T. Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome Proc. Natl. Acad. Sci. USA 2000 97 1032 1037 10.1073/pnas.97.3.1032 10655479 52. Nawaz Z. Lonard D.M. Dennis A.P. Smith C.L. O\u2019Malley B.W. Proteasome-dependent degradation of the human estrogen receptor Proc. Natl. Acad. Sci. USA 1999 96 1858 1862 10.1073/pnas.96.5.1858 10051559 53. Gaughan L. Logan I.R. Neal D.E. Robson C.N. Regulation of androgen receptor and histone deacatylase 1 by Mdm2-mediated ubiquitylation Nucleic Acids Res. 2005 33 13 26 10.1093/nar/gki141 15640443 54. Tyagi R.K. Lavrovsky Y. Ahn S.C. Song C.S. Chatterjee B. Roy A.K. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells Mol. Endocrinol. 2000 14 1162 1174 10.1210/me.14.8.1162 10935541 55. Dai J.L. Burnstein K.L. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA Mol. Endocrinol. 1996 10 1582 1594 10.1210/me.10.12.1582 8961268 56. Black B.E. Vitto M.J. Gioeli D. Spencer A. Afshar N. Conaway M.R. Weber M.J. Paschal B.M. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions Mol. Endocrinol. 2004 18 834 850 10.1210/me.2003-0145 14684849 57. Kinyamu H.K. Chen J. Archer T.K. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors J. Mol. Endocrinol. 2005 34 281 297 10.1677/jme.1.01680 15821097 58. Kang Z. J\u00e4nne O.A. Palvimo J.J. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor Mol. Endocrinol. 2004 18 2633 2648 10.1210/me.2004-0245 15308689 59. Fu M. Wang C. Reutens A.T. Wang J. Angeletti R.H. Siconolfi-Baez L. Ogryzko V. Avantaggiati M.L. Pestell R.G. p300 and p300/cAMP response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation J. Biol. Chem. 2000 275 20853 20860 10.1074/jbc.M000660200 10779504 60. Daujat S. Bauer U.M. Shah V. Turner B. Berger S. Kouzarides T. Crosstalk between CARM1 methylation and CBP acetylation on histone H3 Curr. Biol. 2002 12 2090 2097 10.1016/S0960-9822(02)01387-8 12498683 61. Marshall T.W. Link K.A. Petre-Draviam C.E. Knudsen K.E. Differential requirement of SWI/SNF for androgen receptor activity J. Biol. Chem. 2003 278 30605 30613 10.1074/jbc.M304582200 12775722 62. Wang Q. Sharma D. Ren Y. Fondell J.D. A coregulatory role for the TRAP-Mediator complex in androgen receptor-mediated gene expression J. Biol. Chem. 2002 277 42852 42858 10.1074/jbc.M206061200 12218053 63. Huang Z.Q. Li J. Sachs L.M. Cole P.A. Wong J. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription EMBO J. 2003 22 2146 2155 10.1093/emboj/cdg219 12727881 64. Lee D.K. Chang C. Molecular communication between androgen receptor and general transcription machinery J. Steroid Biochem. Mol. Biol. 2003 84 41 49 10.1016/S0960-0760(03)00005-0 12648523 65. Svejstrup J.Q. The RNA polymerase II transcription cycle: cycling through chromatin Biochim. Biophys. Acta 2004 1677 64 73 15020047 66. Kang Z. Pirskanen A. J\u00e4nne O.A. Palvimo J.J. Involvement of proteasome in the dynamic assembley of the androgen receptor transcription complex J. Biol. Chem. 2002 277 48366 48371 10.1074/jbc.M209074200 12376534 67. Hager G.L. Nagaich A.K. Johnson T.A. Walker D.A. John S. Dynamics of nuclear receptor movement and transcription Biochim. Biophys. Acta 2004 1677 46 51 15020044 68. Dennis A.P. O\u2019Malley B.W. Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription J. Steroid Biochem. Mol. Biol. 2005 93 139 151 10.1016/j.jsbmb.2004.12.015 15860256 69. Lin H.K. Altuwaijri S. Lin W.J. Kan P.Y. Collins L.L. Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells J. Biol. Chem. 2002 277 36570 36576 10.1074/jbc.M204751200 12119296 70. Makino Y. Yoshida T. Yogosawa S. Tanaka K. Muramatsu M. Tamura T. Multiple mammalian proteasomal ATPases, but not proteasome itself, are associated with TATA-binding protein and a novel transcriptional activator, TIP 120 Genes Cells 1999 4 529 539 10.1046/j.1365-2443.1999.00277.x 10526239 71. Gonzalez F. Delahodde A. Kodadek T. Johnston S.A. Recruitment of a 19S proteasome subcomplex to an activated promoter Science 2002 296 548 550 10.1126/science.1069490 11964484 72. Ferdous A. Kodadek T. Johnston S.A. A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II Biochemistry 2002 41 12798 12805 10.1021/bi020425t 12379122 73. vom Baur E. Zechel C. Heery D. Heine M.J. Garnier J.M. Vivat V. Le Douarin B. Gronemeyer H. Chambon P. Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 EMBO J. 1996 15 110 124 8598193 74. Ikezoe T. Yang Y. Saito T. Koeffler H.P. Taguchi H. Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells Cancer Sci. 2004 95 271 275 10.1111/j.1349-7006.2004.tb02215.x 15016328 75. Sun L. Chen Z.J. The novel functions of ubiquitination in signaling Curr. Opin. Cell Biol. 2004 16 119 126 10.1016/j.ceb.2004.02.005 15196553 76. Salghetti S.E. Caudy A.A. Chenoweth J.G. Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin Science 2001 293 1651 1653 10.1126/science.1062079 11463878 77. Burgdorf S. Leister P. Scheidtmann K.H. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination J. Biol. Chem. 2004 279 17524 17534 10.1074/jbc.M313703200 14761944 78. Conaway R.C. Brower C.S. Conaway J.W. Emerging roles of ubiquitin in transcriptional regulation Science 2002 296 1254 1258 10.1126/science.1067466 12016299 79. Pham A.D. Sauer F. Ubiquitin-activating/conjugating activity of TAF II 250, a mediator of activation of gene expression in Drosophila Science 2000 289 2357 2360 10.1126/science.289.5488.2357 11009423 80. Grossman S.R. Deato M.E. Brgnon C. Chan H.M. Kung A.L. Tagami H. Nakatani Y. Livingston D.M. Polyubiquitination of p53 by a ubiquitin ligase activity of p300 Science 2003 300 342 344 10.1126/science.1080386 12690203 81. Ismaili N. Blind R. Garabedian M.J. Stabilisation of the unliganded glucocorticoid receptor by TSG101 J. Biol. Chem. 2005 280 11120 11126 10.1074/jbc.M500059200 15657031 82. Tanner T. Claessens F. Haelens A. The hinge region of the androgen receptor plays a role in proteasome-mediated transcriptional activation Ann. NY Acad. Sci. 2004 1030 587 592 10.1196/annals.1329.068 15659841 83. Thomas M. Dadgar N. Aphale A. Harrell J.M. Kunkel R. Pratt W.B. Lieberman A.P. Androgen receptor acetylation site mutations cause trafficking defects, misfolding and aggregation similar to expanded glutamine tracts J. Biol. Chem. 2004 279 8389 8395 10.1074/jbc.M311761200 14670946 84. Zhou Z.X. Kemppainen J.A. Wilson E.M. Identification of three proline-directed phosphorylation sites in the human androgen receptor Mol. Endocrinol. 1995 9 605 615 10.1210/me.9.5.605 7565807 85. Wong H.Y. Burghoorn J.A. Van Leeuwen M. De Ruiter P.E. Schippers E. Blok L.J. Li K.W. Dekker H.L. De Jong L. Trapman J. Grootegoed J.A. Brinkmann A.O. Phosphorylation of androgen receptor isoforms Biochem. J. 2004 383 267 276 10.1042/BJ20040683 15239671 86. Gioeli D. Ficarro S.B. Kwiek J.J. Aaronson D. Hancock M. Catling A.D. White F.M. Christian R.E. Settlage R.E. Shabanowitz J. Hunt D.F. Weber M.J. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites J. Biol. Chem. 2002 277 29304 29314 10.1074/jbc.M204131200 12015328 87. Perissi V. Aggarwal A. Glass C.K. Rose D.W. Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors Cell 2004 116 511 526 10.1016/S0092-8674(04)00133-3 14980219 88. Zhang J. Guenther M.G. Carthew R.W. Lazar M.A. Proteasomal regulation of nuclear receptor corepressor-mediated repression Genes Dev. 1998 12 1775 1780 9637679 89. Gao X. Mohsin S.K. Gatalica Z. Fu G. Sharma P. Nawaz Z. Decreased expression of E6-associated protein in breast and prostate carcinomas Endocrinology 2005 146 1707 1712 10.1210/en.2004-1198 15691896 90. J\u00e4nne O.A. Moilanen A.M. Poukka H. Rouleau N. Karvonen U. Kotaja N. H\u00e4kli M. Palvimo J.J. Androgen-receptor-interacting nuclear proteins Biochem. Soc. Trans. 2000 28 401 405 10961928 91. Stenoien D.L. Cummings C.J. Adams H.P. Mancini M.G. Patel K. DeMartino G.N. Marcelli M. Weigel N.L. Mancini M.A. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone Hum. Mol. Genet. 1999 8 731 741 10.1093/hmg/8.5.731 10196362 92. Fan M. Bigsby R.M. Nephew K.P. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells Mol. Endocrinol. 2003 17 356 365 10.1210/me.2002-0323 12554766 93. Abreu-Martin M.T. Chari A. Palladino A.A. Craft N.A. Sawyers C.L. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer Mol. Cell. Biol. 1999 19 5143 5154 10373563 94. Yeh S. Lin H.K. Kang H.Y. Thin T.H. Lin M.F. Chang C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells Proc. Natl. Acad. Sci. USA 1999 96 5458 5463 10.1073/pnas.96.10.5458 10318905 95. Darne C. Veyssiere G. Jean C. Phorbol ester causes ligand-independent activation of the androgen receptor Eur. J. Biochem. 1998 256 541 549 10.1046/j.1432-1327.1998.2560541.x 9780230 96. Nazareth L.V. Weigel N.L. Activation of the human androgen receptor through a protein kinase A signaling pathway J. Biol. Chem. 1996 271 19900 19907 10.1074/jbc.271.33.19900 8702703 97. Veldscholte J. Ris-Stalpers C. Kuiper G.G. Jenster G. Berrevoets C. Claassen E. van Rooij H.C. Trapman J. Brinkmann A.O. Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens Biochem. Biophys. Res. Commun. 1990 173 534 540 10.1016/S0006-291X(05)80067-1 2260966 98. Koivisto P. Visakorpi T. Kallioniemi O.P. Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer Scand. J. Clin. Lab. Invest. Suppl. 1996 226 57 63 10.3109/00365519609168299 8981668 99. Culig Z. Hobisch A. Cronauer M.V. Cato A.C.B. Hittmair A. Radmayr C. Eberle J. Bartsch G. Klocker H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone Mol. Endocrinol. 1993 7 1541 1550 10.1210/me.7.12.1541 8145761 100. Veldscholte J. Voorhorst-Ogink M.M. Bolt-de Vries J. van Rooij H.C. Trapman J. Mulder E. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids Biochim. Biophys. Acta 1990 1052 187 194 10.1016/0167-4889(90)90075-O 2322591 101. Cha T.L. Qiu L. Chen C.T. Wen Y. Hung M.C. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth Cancer Res. 2005 65 2287 2295 10.1158/0008-5472.CAN-04-3250 15781642 102. Pajonk F. van Ophoven A. McBride W.H. Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells Cancer Res. 2005 65 4836 4843 10.1158/0008-5472.CAN-03-2749 15930304 103. Schneekloth J.S. Fonseca F.N. Koldobskiy M. Mandal A. Deshaies R. Sakamoto K. Crews C.M. Chemical genetic control of protein levels: selective in vivo targeted degradation J. Am. Chem. Soc. 2004 126 3748 3754 10.1021/ja039025z 15038727 104. Prescott J. Coetzee G.A. Molecular chaperones throughout the life cycle of androgen receptor Cancer Lett. 2006 231 12 19 10.1016/j.canlet.2004.12.037 16356826 105. Vanaja D.K. Mitchell S.H. Toft D.O. Young C.Y.F. Effect of geldanamycin on androgen receptor function and stability Cell Stress Chaperones 2002 7 55 64 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2 11894840 106. Kuduk S.D. Harris C.R. Zheng F.F. Sepp-Lorenzino L. Ouerfelli Q. Rosen N. Danishefsky S.J. Synthesis and evaluation of geldanamycin-testosterone hybrids Bioorg. Med. Chem. Lett. 2000 10 1303 1306 10.1016/S0960-894X(00)00208-0 10866406",
    "full_text_abstract": "The androgen receptor (AR) is a transcription factor belonging to the family of nuclear receptors which mediates the action of androgens in the development of urogenital structures. AR expression is regulated post-translationally by the ubiquitin/proteasome system. This regulation involves more complex mechanisms than typical degradation. The ubiquitin/proteasome system may regulate AR via mechanisms that do not engage in receptor turnover. Given the critical role of AR in sexual development, this complex regulation is especially important. Deregulation of AR signalling may be a causal factor in prostate cancer development. AR is the main target in prostate cancer therapies. Due to the critical role of the ubiquitin/proteasome system in AR regulation, current research suggests that targeting AR degradation is a promising approach."
}